{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:14:12Z","timestamp":1769073252685,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/s0145-2126(03)00008-0","type":"journal-article","created":{"date-parts":[[2003,2,17]],"date-time":"2003-02-17T19:46:16Z","timestamp":1045511176000},"page":"783-788","source":"Crossref","is-referenced-by-count":47,"title":["Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan"],"prefix":"10.1016","volume":"27","author":[{"given":"Takashi","family":"Shimamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Niho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Teramura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Omine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(03)00008-0_BIB1","first-page":"150","article-title":"Immunological abnormalities in myelodysplastic syndromes","volume":"33","author":"Hamblin","year":"1996","journal-title":"Sem. Hematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0925-5710(97)00042-X","article-title":"Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients","volume":"66","author":"Okamoto","year":"1997","journal-title":"Int. J. Hematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/jcp.38.8.908","article-title":"Immune abnormalities in myelodysplastic syndromes","volume":"38","author":"Economopoulos","year":"1985","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1986.tb07504.x","article-title":"Immunological abnormalities in myelodysplastic syndromes","volume":"63","author":"Mufti","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.2830220104","article-title":"Immunonoregulatory abnormalities in myelodysplastic disorders","volume":"22","author":"Baumann","year":"1986","journal-title":"Am. J. Hematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0090-1229(87)90006-7","article-title":"Immunogloblin synthesis in myelodysplastic syndromes: normal B-cell and immunoregulatory T-cell functions","volume":"42","author":"Merchav","year":"1987","journal-title":"Clin. Immunol. Immunopatol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E","article-title":"Immunologic indices in myelodysplastic syndromes","volume":"61","author":"Colombat","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0609.1991.tb01571.x","article-title":"Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis","volume":"47","author":"Symeonidis","year":"1991","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1995.tb00231.x","article-title":"Immune-mediated complications in patients with myelodysplastic syndromes\u2014clinical and cytogenetic features","volume":"55","author":"Billstr\u00f6em","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1992.tb08238.x","article-title":"Clonal lymphocytes are detectable in only some cases of MDS","volume":"81","author":"Culligan","year":"1992","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1993.tb04695.x","article-title":"Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms","volume":"83","author":"Tsukamoto","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB13","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood.V85.12.3367.bloodjournal85123367","article-title":"The treatment of acquired aplastic anemia","volume":"85","author":"Young","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2141.1997.4423249.x","article-title":"Anti-thymocyte globulin for patients with myelodysplastic syndrome","volume":"99","author":"Molldrem","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y","article-title":"Immunosuppressive therapy for hypoplastic myelodysplastic syndrome","volume":"79","author":"Biesma","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.1998.00551.x","article-title":"Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow","volume":"100","author":"Jonasova","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2141.2001.02925.x","article-title":"Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements","volume":"114","author":"Shimamoto","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s002770100360","article-title":"Immunosuppressive therapy for patients with refractory anemia","volume":"80","author":"Asono","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0145-2126(03)00008-0_BIB19","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberag","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB20","first-page":"3671","article-title":"Report of an international working group to standardize response criteria for myelodysplastic syndromes","volume":"96","author":"Cheson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB21","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V84.12.4257.bloodjournal84124257","article-title":"Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporin-dependent aplastic anemia","volume":"84","author":"Nakao","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0039.1994.tb02375.x","article-title":"Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals","volume":"44","author":"Hashimoto","year":"1994","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0145-2126(03)00008-0_BIB23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.leu.2401665","article-title":"Good response to cyclosporin therapy in patients with myelodysplastic syndromes having the HLA-DRB1\u22171501 allele","volume":"14","author":"Okamoto","year":"2000","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:13:23Z","timestamp":1584465203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0145212603000080"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(03)00008-0","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}